This group found that PD-L1 expression on tumor cells was directly correlated with tumor differentiation while PD-L2 expression was inversely associated, hence suggested that combined assessment of PD-L1 and PD-L2 expression may be considered clinically significant for ICIs-treatment regime in NSCLC patients (54). Here, PDCD1LG2 is linked to non-small cell lung carcinoma.